AbbVie

AbbVie plant workers in Ireland threaten to strike over pay dispute: reports FiercePharma16:32
AbbVie's Cork plant hit with industrial action notice by trade union members Irish Examiner10:51
AbbVie files suit challenging Tennessee’s contract pharmacy law Bloomberg Law17:07
Are Wall Street analysts predicting AbbVie stock will climb or sink? Barchart13:15
AbbVie to present at the bank of America securities healthcare conference PR Newswire (Press Release)13:01
AbbVie bags first approval for cancer ADC Emrelis pharmaphorum12:00
'We've fought for this for years': Union at Cork's AbbVie pharma plant demands collective… Cork Beo15:36

Latest News

Yesterday
Perion, Sea, KKR, Chimera, AbbVie: Trending by Analysts TipRanks10:05 17-May-25
In the last 7 days
AbbVie’s Emrelis granted FDA accelerated approval to treat advanced lung cancer PMLiVE12:31 16-May-25
7th Circ. Weighs AbbVie Whistleblower's Drug Marketing Suit Law36004:21 16-May-25
FDA awards cancer drug approvals to AbbVie and MSD Pharmaceutical Technology02:00 16-May-25
US FDA clears Abbvie’s c-Met lung cancer ADC BioWorld18:13 15-May-25
AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer Zacks14:54 15-May-25
AbbVie Cancer Drug Approval Fails to Lift ABBV Stock TipRanks13:35 15-May-25
AbbVie bags first approval for cancer ADC Emrelis pharmaphorum12:00 15-May-25
AbbVie expands siRNA push with $335m ADARx deal Pharmaceutical Technology11:56 15-May-25
AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas Pharmaceutical Business Review11:43 15-May-25
AbbVie Pays $335m Up Front To Partner With ADARx On siRNA Therapeutics Scrip Pharma Intelligence23:37 14-May-25
Yes siRNA: Adarx/Abbvie tie-up worth “several billion” dollars BioWorld22:31 14-May-25
AbbVie On MFN: “We Have To Take It Seriously” Scrip Pharma Intelligence22:16 14-May-25
AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis FiercePharma20:46 14-May-25
FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer ENDPOINTS20:08 14-May-25
U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung … AbbVie (Press Release)18:12 14-May-25
AbbVie plant workers in Ireland threaten to strike over pay dispute: reports FiercePharma16:32 14-May-25
'We've fought for this for years': Union at Cork's AbbVie pharma plant demands collective… Cork Beo15:36 14-May-25
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know Zacks15:06 14-May-25
AbbVie doubles down on siRNA with $335M upfront bet on ADARx ENDPOINTS14:03 14-May-25
AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA… AbbVie (Press Release)13:59 14-May-25
AbbVie Expands Board, Appoints New Independent Director TipRanks11:41 13-May-25
Techbio Pioneer Etcembly Signs Deal With DJS Antibodies, Part of AbbVie, to Accelerate Antibody … Business Wire (Press Release)00:02 13-May-25
SIPTU members serve notice of industrial action at AbbVie RTE19:25 12-May-25
See Which Of The Latest 13F Filers Holds ABBV Nasdaq17:36 12-May-25
AbbVie remains king in doctors’ perception of immunology drugmakers, but J&J regains some ground FiercePharma16:11 12-May-25
Union members to launch industrial action at pharma giant Cork factory Cork Beo13:06 12-May-25
AbbVie's Cork plant hit with industrial action notice by trade union members Irish Examiner10:51 12-May-25
U.S. politicians dump this pharma stock days before Trump’s drug price order Finance in Bold10:42 12-May-25
In the last month
Dutch Court Case On Drug Humira Assesses Whether Its Price Was ‘Excessive’ Forbes19:35 9-May-25
The People vs. AbbVie Medicines Law & Policy03:29 9-May-25
Cervical Cancer Treatment Global Market Overview 2024-2030 Featuring AbbVie, Alnylam,… Business Wire (Press Release)10:57 8-May-25
Time for Action on Ovarian Cancer PoliticsHome10:13 8-May-25
AbbVie Files Suit Challenging Tennessee’s Contract Pharmacy Law Bloomberg Law17:07 7-May-25
The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie Barchart14:57 7-May-25
Are Wall Street Analysts Predicting AbbVie Stock Will Climb or Sink? Barchart13:15 7-May-25
AbbVie to Present at the Bank of America Securities Healthcare Conference PR Newswire (Press Release)13:01 6-May-25
AbbVie’s Skyrizi retakes top TV ad spending spot for the first time all year FiercePharma16:31 5-May-25
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? The Motley Fool09:58 4-May-25
Genmab to submit FDA application for lymphoma therapy Pharmafile16:43 2-May-25
BOTOX® Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through… PR Newswire (Press Release)22:01 1-May-25
PTAB Axes AbbVie Unit's Cancer Drug Patent As Invalid Law36023:15 30-Apr-25
Netflix, Sherwin-Williams, AbbVie And More On CNBC's 'Final Trades' Benzinga13:44 30-Apr-25
Allergan Aesthetics Announces Inaugural Allergan Medical Institute® (AMI) Training Centers Faculty AbbVie (Press Release)13:29 30-Apr-25
AbbVie’s JAK inhibitor Rinvoq granted FDA approval to treat giant cell arteritis PMLiVE12:27 30-Apr-25
FDA approves AbbVie’s upadacitinib for giant cell arteritis Pharmaceutical Technology12:14 30-Apr-25
AbbVie (NYSE:ABBV) Receives FDA Approval For RINVOQ In Treating Giant Cell Arteritis Simply Wall St21:12 29-Apr-25
AbbVie Scores FDA Approval For Its Blockbuster Drug Rinvoq To Treat Type of Arthritis Benzinga19:45 29-Apr-25
Stock Of The Day: AbbVie's Rally Looks Stretched — Could A Reversal Be Next? Benzinga16:34 29-Apr-25
AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data ENDPOINTS15:26 29-Apr-25
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:06 29-Apr-25
Why AbbVie Stock Trounced the Market Today The Motley Fool00:12 29-Apr-25
CERE Investors Have Opportunity to Lead Cerevel Therapeutics Holdings, Inc. Securities Fraud… PR Newswire (Press Release)00:06 29-Apr-25
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report Yahoo! US22:47 28-Apr-25
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst Benzinga20:45 28-Apr-25
AbbVie makes its tariffs-driven investment play pharmaphorum11:04 28-Apr-25
Should Investors Be Worried About Dividend King AbbVie? The Motley Fool09:46 28-Apr-25
AbbVie Stock (ABBV) Up 8% on the Week as Company Soars Past Q1 Expectations TipRanks19:07 27-Apr-25
AbbVie Reports Strong Q1 2025 Financial Results TipRanks05:09 26-Apr-25
AbbVie Earnings Call: Strong Growth Amid Challenges TipRanks01:55 26-Apr-25
Why AbbVie Stock Topped the Market Today The Motley Fool22:23 25-Apr-25
Market movers: Tesla, Alphabet, Intel, AbbVie... Proactive Investors (US)20:32 25-Apr-25
AbbVie eyes $10B US expansion amid sector-specific tariff threat ENDPOINTS20:27 25-Apr-25
AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View Barchart19:25 25-Apr-25
Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss Yahoo! UK & Ireland18:17 25-Apr-25
AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift Yahoo! US17:52 25-Apr-25
Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years FiercePharma17:05 25-Apr-25
AbbVie Raises Profit Outlook But Flags Tariff Risks In Pharma Sector Benzinga16:05 25-Apr-25
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say Zacks15:36 25-Apr-25
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy Entrepreneur Magazine15:12 25-Apr-25
AbbVie (ABBV) Q1 Earnings and Revenues Beat Estimates Zacks14:55 25-Apr-25
AbbVie lifts guidance as Q1 results top expectations Proactive Investors (US)14:35 25-Apr-25
AbbVie (NYSE:ABBV) Reports Bullish Q1 Barchart13:39 25-Apr-25
AbbVie files fast-acting Botox successor in US pharmaphorum13:24 25-Apr-25
ABBV Earnings: AbbVie Blows Past Q1 Estimates TipRanks13:01 25-Apr-25
AbbVie lifts profit forecast on strong sales of newer immunology drugs Yahoo! UK & Ireland12:50 25-Apr-25
AbbVie Q1 earnings: Immunology still a powerhouse as Skyrizi, Rinvoq hit $5B combined ENDPOINTS12:50 25-Apr-25
AbbVie Reports First-Quarter 2025 Financial Results AbbVie (Press Release)12:48 25-Apr-25
Louisiana v. AbbVie, Inc. U.S. Chamber of Commerce (Press Release)22:33 24-Apr-25
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE)… PR Newswire (Press Release)13:31 24-Apr-25
Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA Zacks01:14 24-Apr-25
The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi Zacks15:34 23-Apr-25
Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades' Benzinga13:40 23-Apr-25
AbbVie's Pipeline May Be A 2026 Story, But Analyst Likes The Setup Now Benzinga22:11 22-Apr-25
Sligo’s Abbvie win a first Interfirms All Ireland title The Sligo Champion21:47 22-Apr-25
Mayo men to the fore as AbbVie win All-Ireland Interfirms title The Mayo News16:10 22-Apr-25
Seeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics Zacks15:29 22-Apr-25
Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? Zacks14:38 22-Apr-25
AbbVie (ABBV) Stock Moves -1.64%: What You Should Know Zacks23:53 21-Apr-25
US drugmaker AbbVie marks entry into the cancer drugs segment in India with Venetoclax The Hindu Business Line10:00 21-Apr-25
Is AbbVie Stock a Buy? The Motley Fool13:17 20-Apr-25
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks16:10 18-Apr-25

      
            
      
    view more headlines
   
      
      
      
17 May 10:05
   

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

AbbVie

Latest News

AbbVie News

Biotech Top Stories

UK Top Stories

World Top Stories